DARU-Journal of Pharmaceutical Sciences

Papers
(The TQCC of DARU-Journal of Pharmaceutical Sciences is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Short and long term impacts of COVID-19 on the pharmaceutical sector124
Therapeutic application of Carica papaya leaf extract in the management of human diseases57
Surging trends in prescriptions and costs of antidepressants in England amid COVID-1952
Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis42
A new sesquiterpenoid from the shoots of Iranian Daphne mucronata Royle with selective inhibition of STAT3 and Smad3/4 cancer-related signaling pathways39
A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities34
COVID-19 vaccines: ethical framework concerning human challenge studies32
Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release30
Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indi28
Bibenzyls and bisbybenzyls of bryophytic origin as promising source of novel therapeutics: pharmacology, synthesis and structure-activity27
COVID-19 and off label use of drugs: an ethical viewpoint24
Polyherbal combination for wound healing: Matricaria chamomilla L. and Punica granatum L.21
Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review20
HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy18
Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition18
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir18
Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety16
Colloidal and vesicular delivery system for herbal bioactive constituents15
The effect of ethanol evaporation on the properties of inkjet produced liposomes15
Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy15
Chromone–lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities14
Design and evaluation of a novel nanodrug delivery system for reducing the side effects of clomiphene citrate on endometrium14
Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity14
Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase13
Comparison of diclofenac with apigenin-glycosides rich Clinacanthus nutans extract for amending inflammation and catabolic protease regulations in osteoporotic-osteoarthritis rat model12
Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis12
Is there any potential management against COVID-19? A systematic review and meta-analysis11
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study11
Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer11
Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial11
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-211
Alleviation of prilocaine-induced epileptiform activity and cardiotoxicity by thymoquinone11
Wound healing and anti-inflammatory effects of bacterial cellulose coated with Pistacia atlantica fruit oil10
Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis10
West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-1910
The synergistic anticancer effects of ReoT3D, CPT-11, and BBI608 on murine colorectal cancer cells10
Antiprotozoal activity of diterpenoids isolated from Zhumeria majdae- absolute configuration by circular dichroism9
Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial9
Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor9
Putative role of natural products as Protein Kinase C modulator in different disease conditions8
Synthesis and evaluation of in vitro cytotoxic effects of triazol/spiroindolinequinazolinedione, triazol/indolin-3-thiosemicarbazone and triazol/thiazol-indolin-2-one conjugates8
Validated spectrophotometric method for quantification of total triterpenes in plant matrices8
Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection8
Molecular docking of alpha-enolase to elucidate the promising candidates against Streptococcus pneumoniae infection8
0.017325878143311